Cherrystone Angel Group
Status
ACTIVE
Global HQ
Providence, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Health Tech
- Fintech
- Data Science
- Media
- Entertainment
- IoT
About
Cherrystone Angel Group is an angel investment group that focuses on providing financial support and expertise to early-stage biopharma, medical device, and technology startups in the New England region.
Cherrystone Angel Group is an angel investment group that focuses on providing financial support and expertise to early-stage biopharma, medical device, and technology startups in the New England region.
Investment Thesis
Cherrystone Angel Group focuses on early stage investments in a range of industries, with a focus on innovation, growth potential, and scalable solutions.
Manager's Experience
With a robust background in venture capital, the fund manager has successfully led investments across technology, healthcare, and consumer sectors, emphasizing early-stage opportunities. Active primarily in North America and Europe, they have completed over 30 deals, showcasing a strong track record of identifying high-potential startups. Notable exits include several multi-million dollar acquisitions, reflecting a strategic approach that blends operator-first insights with data-driven analysis. Their investment philosophy hinges on thematic trends, positioning them as a forward-thinking player in the competitive landscape.
Team
Jennifer Schwall
Robert Nickerson
Robert Manning
Neal Frankel
Michael Wiggins
Ken Kirsch
Jon Dodd